FDA Inspection 1209999 — Bayer AG
The FDA completed an inspection of Bayer AG on May 13, 2022 in Leverkusen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 13, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leverkusen (Germany)
Additional Details
Mutual Recognition Agreement (MRA)